Patient Power Community member, Francis, asks “Can refractory, high-risk myeloma patients become refractory to daratumumab?” Dr. Jatin Shah from the University of Texas MD Anderson Cancer Center responds to this question and goes on to discuss promising treatment options in clinical trials, specifically related to immunotherapy and checkpoint inhibitors.
Can High-Risk Myeloma Patients Become... - Myeloma America S...
Can High-Risk Myeloma Patients Become Refractory to Certain Monoclonal Antibodies?
Written by
mcints
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
multiple myeloma on pancreatic and pelvic as extramedullary plasmacytoma
Our Mayo Clinic psychiatrist mentioned most cancer patients have the treatment of maintenance...
Myeloma relapse.
Diagnosed with MM in 2006. My symptoms where only foggy vision. After 9 months and multiple tests...
